Company profile
APIS Assay Technologies Ltd.
We are committed to realise the clinical potential of systems biology in the diagnosis and personalisation of treatment.
- Industry
- Biotechnology Research
- Employees
- 54
- Headquarters
- MANCHESTER, UK
- LinkedIn followers
- 5,067
- Office locations
- 1
APIS Assay Technologies Ltd. company summary
APIS Assay Technologies Ltd. is a company in the Biotechnology Research industry, headquartered in MANCHESTER, UK. On LinkedIn the company has around 54 employees and 5,067 followers.
What technology does APIS Assay Technologies Ltd. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About APIS Assay Technologies Ltd.
APIS is leveraging systems biology, interrogating multi-OMICs biodata, and deploying innovative ‘Clickmer’ ligand binding technology, for the validation and translation of biomarker and therapeutic assets into clinical utility. APIS has deep expertise and capabilities in IVD development of molecular & immune assays for ultimate product realisation as diagnostic tests. In addition, APIS' expertise in bioinformatics and software development is offered as an agile service to our clients, to develop bespoke, end-to-end multi-OMICs solutions and platform development. APIS has also developed a broad breast oncology product portfolio: The APIS Breast Cancer Subtyping Kit is a reproducible RT-qPCR based IVD product (in certain territories) and RUO product for detecting standard (HER2, ER, PR, Ki67) and novel proliferative biomarkers. The APIS ESR1 Mutations Kit is a qPCR assay for the sensitive detection of eleven key mutations within the oestrogen receptor gene. Coming soon - the new APIS PIK3CA Mutations Kit is a qPCR assay for the sensitive detection of key mutations in the PIK3CA gene.
Where is APIS Assay Technologies Ltd. located?
APIS Assay Technologies Ltd. lists 1 location.
Compare companies similar to APIS Assay Technologies Ltd.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
APIS Assay Technologies Ltd. apisassay.com | Biotechnology Research | 54 | - | MANCHESTER, UK |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about APIS Assay Technologies Ltd.
What does APIS Assay Technologies Ltd. do?
APIS is leveraging systems biology, interrogating multi-OMICs biodata, and deploying innovative ‘Clickmer’ ligand binding technology, for the validation and translation of biomarker and therapeutic assets into clinical utility. APIS has deep expertise and capabilities in IVD development of molecular & immune assays for ultimate product realisation as diagnostic tests. In addition, APIS' expertise in bioinformatics and software development is offered as an agile service to our clients, to develop bespoke, end-to-end multi-OMICs solutions and platform development. APIS has also developed a broad breast oncology product portfolio: The APIS Breast Cancer Subtyping Kit is a reproducible RT-qPCR based IVD product (in certain territories) and RUO product for detecting standard (HER2, ER, PR, Ki67) and novel proliferative biomarkers. The APIS ESR1 Mutations Kit is a qPCR assay for the sensitive detection of eleven key mutations within the oestrogen receptor gene. Coming soon - the new APIS PIK3CA Mutations Kit is a qPCR assay for the sensitive detection of key mutations in the PIK3CA gene.
How many employees does APIS Assay Technologies Ltd. have?
APIS Assay Technologies Ltd. has around 54 employees on LinkedIn.
Where is APIS Assay Technologies Ltd. headquartered?
APIS Assay Technologies Ltd. is headquartered in MANCHESTER, UK.
Build a lead list from companies like APIS Assay Technologies Ltd.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.